Cagrilintide: Complete Research Guide & Chemical Profile

Cagrilintide, also known by its research designations AM833 and NN9838, is a synthetic long-acting analog of the naturally occurring hormone amylin. This peptide compound has garnered significant attention in metabolic research due to its enhanced pharmacokinetic properties compared to native amylin.

The compound features a molecular weight of approximately 3,950 Da and maintains structural similarities to human amylin while incorporating modifications that extend its biological half-life to roughly 7 days. This extended duration makes Cagrilintide particularly valuable for laboratory studies investigating sustained metabolic effects.

Cagrilintide belongs to the class of amylin receptor agonists and is characterized by its high stability and prolonged activity profile. The peptide's chemical structure includes strategic amino acid modifications that enhance its resistance to enzymatic degradation while preserving its biological activity at amylin receptors.

Research into Cagrilintide has primarily focused on its potential applications in metabolic disorders and obesity research. Studies indicate that this long-acting amylin analog demonstrates promising characteristics in laboratory models investigating energy balance and metabolic regulation.

Clinical research has examined Cagrilintide's effects on various metabolic parameters, including glucose homeostasis, gastric emptying, and food intake regulation. These investigations have revealed that the compound maintains the beneficial properties of native amylin while offering the advantage of reduced dosing frequency due to its extended half-life.

Preclinical studies have demonstrated that Cagrilintide exhibits dose-dependent effects on metabolic processes in laboratory settings. Research suggests that the compound's prolonged activity profile makes it suitable for studies requiring sustained amylin receptor activation over extended periods.

Ongoing research continues to explore the compound's pharmacodynamic properties, with particular interest in its potential synergistic effects when combined with other metabolic regulatory peptides in experimental protocols.

Cagrilintide exerts its biological effects through selective activation of amylin receptors, which are G-protein coupled receptors found in various tissues throughout the body. The compound's mechanism of action closely mimics that of endogenous amylin while providing enhanced stability and duration of activity.

Upon binding to amylin receptors, Cagrilintide activates intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) elevation. This activation leads to various downstream effects including modulation of calcium ion channels and activation of protein kinase A pathways.

The compound demonstrates high binding affinity for amylin receptors in the central nervous system, particularly in regions associated with satiety and metabolic control. Research indicates that Cagrilintide's receptor binding profile closely resembles that of native amylin while maintaining superior pharmacokinetic characteristics.

Laboratory studies suggest that Cagrilintide influences multiple aspects of metabolic regulation through its amylin receptor activity. These effects include modulation of gastric emptying rates, influence on glucose homeostasis, and regulation of food intake behaviors in experimental models.

The compound's extended half-life allows for sustained receptor activation, which may contribute to more consistent metabolic effects compared to shorter-acting amylin analogs. This characteristic makes Cagrilintide particularly valuable for research protocols requiring prolonged amylin receptor stimulation.

Cagrilintide exhibits several important chemical characteristics that distinguish it from native amylin and contribute to its enhanced stability and prolonged activity profile. Understanding these properties is crucial for proper handling and storage in laboratory settings.

Research-grade Cagrilintide is typically supplied at a purity level of ≥98%, as determined by high-performance liquid chromatography (HPLC) analysis. This high purity standard ensures consistent results in experimental applications and minimizes potential interference from impurities.

Quality control testing for Cagrilintide includes verification of molecular weight through mass spectrometry, purity assessment via HPLC, and endotoxin testing to ensure suitability for biological research applications.

Proper storage conditions are essential for maintaining Cagrilintide's stability and biological activity. The compound should be stored in lyophilized form at temperatures below -20°C, protected from light and moisture.

Once reconstituted, Cagrilintide solutions demonstrate varying stability depending on storage conditions and buffer composition. Research protocols should account for the compound's stability profile when designing experimental timelines and storage procedures.

• Lyophilized powder: Store at -20°C or below
• Reconstituted solutions: Use within specified timeframes based on buffer conditions
• Avoid repeated freeze-thaw cycles to maintain peptide integrity
• Protect from light exposure during storage and handling

Researchers seeking high-quality Cagrilintide for their laboratory studies can find verified suppliers and third-party tested batches on ChemVerify. Our comprehensive database provides detailed information about vendor reliability, product specifications, and independent analytical testing results.

Visit our Cagrilintide product page at /product/cagrilintide to access verified vendor information, compare pricing, and review third-party analytical reports. ChemVerify's rigorous verification process ensures that researchers have access to reliable sources for this important research compound.

Each listed supplier undergoes thorough evaluation of their quality control processes, analytical capabilities, and product consistency. This verification system helps researchers make informed decisions when sourcing Cagrilintide for their experimental protocols.

**What is the molecular weight of Cagrilintide?**

Cagrilintide has a molecular weight of approximately 3,950 Da, making it significantly larger than many other research peptides. This molecular size contributes to its extended half-life and sustained biological activity in laboratory studies.

**How does Cagrilintide differ from native amylin?**

While Cagrilintide maintains the core biological activity of native amylin, it incorporates structural modifications that extend its half-life from minutes to approximately 7 days. This enhancement makes it more suitable for research applications requiring prolonged amylin receptor activation.

**What purity standards should researchers expect?**

Research-grade Cagrilintide should meet a minimum purity standard of ≥98% as determined by HPLC analysis. Reputable suppliers provide comprehensive analytical data including mass spectrometry confirmation and endotoxin testing results.

**What are the optimal storage conditions for Cagrilintide?**

Lyophilized Cagrilintide should be stored at -20°C or below, protected from light and moisture. Reconstituted solutions have limited stability and should be used according to established protocols based on buffer conditions and storage temperature.

**Is Cagrilintide suitable for long-term studies?**

The extended half-life of approximately 7 days makes Cagrilintide particularly suitable for long-term research studies investigating sustained metabolic effects. This characteristic allows for less frequent dosing in experimental protocols compared to shorter-acting amylin analogs.

**What analytical methods are used to verify Cagrilintide quality?**

Quality verification of Cagrilintide typically involves HPLC for purity determination, mass spectrometry for molecular weight confirmation, amino acid analysis for sequence verification, and endotoxin testing for biological research applications.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• Semaglutide: Complete Research Guide → /learn/semaglutide

• Read more: What Not to Combine with Peptides: Laboratory Compatibility Guide → https://www.chemverify.com/learn/what-not-to-combine-with-peptides
• Read more: Peptide Calculator: Reconstitution Mathematics and Laboratory Guidelines → https://www.chemverify.com/learn/peptide-calculator
• Read more: Re-Engineering Insulin for Oral Delivery: Structural Modifications and Formulation Advances → https://www.chemverify.com/learn/insulin-oral-delivery-peptide-engineering
• Read more: GLP-1 Peptides: Receptor Agonist Research and Clinical Trial Evidence → https://www.chemverify.com/learn/glp-1-peptide
• Read more: GLP-1 Receptor Agonists Demonstrate Cardiorenal Protection in Chronic Kidney Disease: Meta-Analysis → https://www.chemverify.com/learn/glp1-receptor-agonists-cardiorenal-protection-ckd